Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01)

The summary for the Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01): The purpose of this limited competition is to extend the activities of the ASSESS AKI consortium to continue an observational cohort of patients with normal renal function and with chronic kidney disease (CKD) who have had an episode of AKI and appropriate control participants to ascertain a) long-term renal functional outcomes, b) long-term cardiovascular disease outcomes, c) quality of life and cognitive functional outcomes, and d) survival. In addition, the utility of putative biomarkers to predict short and long-term outcomes will be assessed. The extension will insure the statistical power and the significance of the study outcomes. The extension will insure the statistical power and significance of the study outcomes. The ASSESS AKI is comprised of three Participating Clinical Centers (PCCs) and a data Coordinating Center. An additional site was added as an ancillary study in 2010.
Federal Grant Title: Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Food and Nutrition Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DK-12-509
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.847
CFDA Descriptions: Diabetes, Digestive, and Kidney Diseases Extramural Research
Current Application Deadline: Nov 21, 2012
Original Application Deadline: Nov 21, 2012
Posted Date: August 30th, 2012
Creation Date: Aug 30, 2012
Archive Date: Dec 22, 2012
Total Program Funding: $2,200,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Understanding the Functional Contributions and Mechanisms of Type 2 Diabetes Disease-assoc...
Limited Competition for the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes Kn...
NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed)
Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Me...
Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Met...
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Molecular Therapy Core Centers
Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2019 FederalGrants.com